Back

Pro-B-type natriuretic peptide strongly predicts major cardiovascular events and cardiovascular mortality in coronary artery disease patients with NAFLD as well as in those without NAFLD

31 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Risk factors: biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Barbara Larcher

0012o00003HdGn8AAF (VIVIT), Feldkirch (Austria)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mrs L. Cosenso-Martin (Sao Jose do Rio Preto, BR)
Abstract Video
Presentation thumbnail
Associate Professor M. Chlabicz (Bialystok, PL)
Abstract Video
Presentation thumbnail
Professor R. Gupta (Jaipur, IN)
Abstract Video
Presentation thumbnail
Professor H. Rosjo (Nordbyhagen, NO)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Risk factors: biomarkers

The Event

Event poster

ESC Congress 2025

31 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of coronary computed tomography angiography parameters, non-alcoholic fatty liver and metabolic syndrome status in symptomatic patients suspected of coronary artery disease
thumbnail
Congress Presentation
Prognostic implications of N-terminal pro-brain natriuretic peptide in patients with Non-ST segment elevation myocardial infarction
thumbnail
Congress Presentation
Incremental prognostic value of metabolic dysfunction-associated fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources